SCHEMBL20318682

SCHEMBL20318682

c1ccc(N2c3ccccc3C3(c4ccccc4-c4ccc(N(c5ccc6c(c5)C(c5ccccc5)(c5ccccc5)c5ccccc5-6)c5ccc6c(c5)C5(c7ccccc7-c7ccccc75)c5ccccc5-6)cc43)c3ccccc32)cc1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
LMNA P02545 1/20 0.36
OPRK1 P41145 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PDK2 Q15119 2/20 0.32
ESR1 P03372 1/20 0.31
ESR2 Q92731 1/20 0.31
CES2 O00748 1/20 0.31
ALDH1A1 P00352 1/20 0.31
BCHE P06276 1/20 0.31
GAA P10253 1/20 0.31
CES1 P23141 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
PGR P06401 1/20 0.31
APP P05067 1/20 0.30
SNCA P37840 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20318678 1.00 MAPT (0.36) MAPTKDM4EMEN1LMNAOPRK1
SCHEMBL20318582 0.97 KDM4E (0.34) MAPTKDM4EMEN1LMNAOPRK1
SCHEMBL20318674 0.95 PDK2 (0.35) MAPTMEN1KMT2APDK2CES2
SCHEMBL20318579 0.94 PDK2 (0.32) MAPTKDM4EMEN1LMNAOPRK1
SCHEMBL20318583 0.94 PDK2 (0.32) MAPTKDM4EMEN1LMNAOPRK1
SCHEMBL22595619 0.93 KDM4E (0.31) MAPTKDM4EMEN1LMNAOPRK1
SCHEMBL22596239 0.93 KDM4E (0.31) MAPTKDM4EMEN1LMNAOPRK1
SCHEMBL22596233 0.93 KDM4E (0.31) MAPTKDM4EMEN1LMNAOPRK1
SCHEMBL19928963 0.93 KDM4E (0.31) MAPTKDM4EMEN1LMNAOPRK1
SCHEMBL20318584 0.93 PGR (0.37) MAPTKDM4EMEN1LMNAOPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10941144-B2 Organic electroluminescence device and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2021-03-09 US disclosed
US-20180179206-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD., (JP) 2018-06-28 US disclosed
US-20180179206-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD., (JP) 2018-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180179206-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE L1CAM, ESR1, CHRM1 MAPT 1871/4885KDM4E 2890/4885MEN1 903/4885
US-10941144-B2 Organic electroluminescence device and electronic device L1CAM, ESR1, CHRM1 MAPT 1871/4885KDM4E 2890/4885MEN1 903/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.